Polydeoxyribonucleotides (pdrns) for use in the treatment of metabolic and/or lactic acidosis and polydeoxyribonucleotide-based compositions for the aforesaid use
EP2663335A1
A composition for the regeneration of atrophic tissues
US2010168050A1
Compounds having antiangiogenic activity
EP2120944A1
A novel use of antidepressant compounds and related compositions
CN101668526A
Antidepressant compounds and compositions related new purposes
EP1514554A1
Oral composition based on natural substances useful in the maintenance of the correct hydration of the skin
EP1417222A1
Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope
